- Home
- DOX vs PEN Comparison
DOX vs PEN Comparison
Compare DOX & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOX
- PEN
- Stock Information
- Founded
- DOX 1982
- PEN 2004
- Country
- DOX United States
- PEN United States
- Employees
- DOX N/A
- PEN N/A
- Industry
- DOX EDP Services
- PEN Medical/Dental Instruments
- Sector
- DOX Technology
- PEN Health Care
- Exchange
- DOX Nasdaq
- PEN Nasdaq
- Market Cap
- DOX 10.2B
- PEN 10.0B
- IPO Year
- DOX 1998
- PEN 2015
- Fundamental
- Price
- DOX $88.00
- PEN $291.61
- Analyst Decision
- DOX Strong Buy
- PEN Buy
- Analyst Count
- DOX 5
- PEN 16
- Target Price
- DOX $101.20
- PEN $287.07
- AVG Volume (30 Days)
- DOX 705.4K
- PEN 509.6K
- Earning Date
- DOX 02-04-2025
- PEN 02-18-2025
- Dividend Yield
- DOX 2.39%
- PEN N/A
- EPS Growth
- DOX N/A
- PEN N/A
- EPS
- DOX 4.31
- PEN 0.36
- Revenue
- DOX $4,869,845,000.00
- PEN $1,194,615,000.00
- Revenue This Year
- DOX N/A
- PEN $13.65
- Revenue Next Year
- DOX $4.21
- PEN $14.30
- P/E Ratio
- DOX $20.71
- PEN $811.72
- Revenue Growth
- DOX N/A
- PEN 12.86
- 52 Week Low
- DOX $74.41
- PEN $148.00
- 52 Week High
- DOX $94.04
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- DOX 55.06
- PEN 65.03
- Support Level
- DOX $85.18
- PEN $264.82
- Resistance Level
- DOX $90.50
- PEN $310.00
- Average True Range (ATR)
- DOX 1.95
- PEN 7.93
- MACD
- DOX 0.22
- PEN 2.79
- Stochastic Oscillator
- DOX 42.79
- PEN 64.07
About DOX Amdocs Limited
Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.